Your browser does not support iframes.
Regional Stocks
Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
NASDAQ Composite
Standard & Poors 500
NYSE COMPOSITE INDX
Gold
Crude Oil
Cadence Pharmaceuticals, Inc.
(NQ:
CADX
)
6.990
USD
+0.120 (+1.75%)
Official Closing Price
/ Updated:
8:10 PM EDT, May 21, 2013
/
Add to My Watchlist
View:
Quote
Overview
Detailed Quote
Charting
Options
Historical Prices
News
All News
Press Releases
Related Stories
Blogs
Podcasts
Research
Quarterly Reports
Insider Filings
Other Filings
Stories about Cadence Pharmaceuticals, Inc.
< Previous
1
2
3
4
5
6
7
Next >
Bio-Wire Equity Surveillance – Closing Bell 5/20/2013
May 20, 2013
Medium and large sized pharmaceutical companies were down by an average of .3-.6% at the closing bell Jumps by % Gain and Mkt Cap Change Biolife Solutions (OTC: BLFS) +34% on spike in trading activity...
Read More
category
RPTP
,
ACAD
,
MDXG
, and 15 more.
from
Bio-Wire.Com
Cadence Pharmaceuticals Earnings Hindsight: Up 6.4% in Last 18 Days (CADX)
May 20, 2013
from
Comtex SmarTrend® News Briefs
Cadence Pharmaceuticals Shares Up 24.4% Since SmarTrend's Buy Recommendation (CADX)
May 06, 2013
from
Comtex SmarTrend® News Briefs
Cadence Pharmaceuticals Has Returned 25.8% Since SmarTrend Recommendation (CADX)
April 26, 2013
from
Comtex SmarTrend® News Briefs
Recent 52-Week High Exceeded in Shares of Cadence Pharmaceuticals (CADX)
April 12, 2013
from
Comtex SmarTrend® News Briefs
Stocks Hitting 52-Week Highs
April 05, 2013
Cadence Pharmaceuticals (NASDAQ: CADX ) shares reached a new 52-week high of $6.91. Cadence shares have jumped 104.81% over the past 52 weeks, while the S&P 500 index has gained 12.86% in the same...
Read More
category
Benzinga
,
Movers
,
OMPI
, and 7 more.
from
Latest Articles from Benzinga.com
Uptrend Call Working As Cadence Pharmaceuticals Stock Rises 20.7% (CADX)
April 05, 2013
from
Comtex SmarTrend® News Briefs
Biotech Movers: Analyst Upgrades Lift Puma
April 01, 2013
Read More
category
NASDAQ:IDIX
,
NASDAQ:ARIA
,
NASDAQ:ARRY
, and 3 more.
from
InvestorPlace - Latest Headlines
Watch for Continued Gains in Shares of Cadence Pharmaceuticals (CADX)
March 26, 2013
from
Comtex SmarTrend® News Briefs
Recent 52-Week High Exceeded in Shares of Cadence Pharmaceuticals (CADX)
March 22, 2013
from
Comtex SmarTrend® News Briefs
Cadence Pharmaceuticals: The Winning Streak Continues (CADX)
March 21, 2013
from
Comtex SmarTrend® News Briefs
Significant Catalysts And Company PR Error Present Significant Opportunity In AcelRx Pharmaceuticals
March 20, 2013
category
Pharmaceuticals
from
Trefis
Cadence Pharmaceuticals Appoints Stephen Newman, M.D., to its Board of Directors
March 14, 2013
Cadence Pharmaceuticals (NASDAQ: CADX ), a biopharmaceutical company focused on acquiring, in-licensing, developing and commercializing proprietary products principally for use in the hospital setting,...
Read More
category
THC
,
Management
,
Benzinga
, and 2 more.
from
Latest Articles from Benzinga.com
Cadence Pharmaceuticals, Inc. (CADX) Posts Q4 Loss of 25c/Share; Guides FY13 Revs
March 07, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8164812 for the full story.
Read More
from
StreetInsider.com News Articles
Cadence Pharmaceuticals Announces Supply Agreement with Laboratorios Grifols for OFIRMEV Injection
March 06, 2013
Cadence Pharmaceuticals (NASDAQ: CADX ) today announced a new supply agreement with Laboratorios Grifols, S.A. for the development, manufacture and supply of commercial quantities of OFIRMEV...
Read More
category
Management
,
Benzinga
,
Global
, and 6 more.
from
Latest Articles from Benzinga.com
Cadence (CADX) Expects to Exceed Q4 Revenue Estimates
January 23, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8024769 for the full story.
Read More
from
StreetInsider.com News Articles
49.0% Return Seen to Date on SmarTrend Cadence Pharmaceuticals Call (CADX)
January 17, 2013
from
Comtex SmarTrend® News Briefs
Cadence Pharmaceuticals Shares Up 47.1% Since SmarTrend's Buy Recommendation (CADX)
January 09, 2013
from
Comtex SmarTrend® News Briefs
Cadence Pharmaceuticals: The Winning Streak Continues (CADX)
January 07, 2013
from
Comtex SmarTrend® News Briefs
Cadence Pharmaceuticals Has Returned 40.5% Since SmarTrend Recommendation (CADX)
January 02, 2013
from
Comtex SmarTrend® News Briefs
Cadence Pharmaceuticals: The Winning Streak Continues (CADX)
January 02, 2013
from
Comtex SmarTrend® News Briefs
Cadence Pharmaceuticals: The Winning Streak Continues (CADX)
December 24, 2012
from
Comtex SmarTrend® News Briefs
Traders Get Bullish on Shares of Cadence Pharmaceuticals, Shares Up 5.6% (CADX)
December 14, 2012
from
Comtex SmarTrend® News Briefs
Cadence (CADX) Terminates Agreement to Acquire Incline Therapeutics (MDCO)
December 12, 2012
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=7941662 for the full story.
Read More
from
StreetInsider.com News Articles
Cadence Pharmaceuticals (CADX) halted dissemination
December 12, 2012
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=7941660 for the full story.
Read More
from
StreetInsider.com News Articles
Stock to Watch: Cadence Pharmaceuticals Up 5.3% (CADX)
November 29, 2012
from
Comtex SmarTrend® News Briefs
Perrigo (PRGO) to Settle Hatch-Waxman Litigation Over Generic Ofirmev
November 28, 2012
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=7907648 for the full story.
Read More
from
StreetInsider.com News Articles
Cadence (CADX), Perrigo (PRGO) Enter Settlement License Agreement Over OFIRMEV
November 28, 2012
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=7907250 for the full story.
Read More
from
StreetInsider.com News Articles
Cadence Pharmaceuticals, Inc. (CADX) Reports In-Line Q3 EPS
November 05, 2012
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=7845426 for the full story.
Read More
from
StreetInsider.com News Articles
4 Pharmaceutical Stocks to Sell Now
September 21, 2012
Read More
category
NASDAQ:DRRX
,
Stocks to Sell
,
NASDAQ:CORT
, and 2 more.
from
InvestorPlace - Latest Headlines
< Previous
1
2
3
4
5
6
7
Next >
Stock Market XML and JSON Data API
provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays.
Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
Press Release Service
provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates
Bots go here
Your browser does not support iframes.